← Leaderboards
John M. Schallenkamp
Montana Cancer Consortium
$4,349,538
Attributed
$9,962,622
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.1M · FY2014–25$2M$1.5M$1M$500K$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$9,962,622 · 1
By mechanism
UG1$9,962,622 · 1
Top collaborators
- Allen Warren Jeffrey7 shared
- Benjamin T. Marchello5 shared
- Justin Neal Bottsford-Miller4 shared
Most similar at Montana Cancer Consortium
Same institution · by research overlap
- Benjamin T. Marchello$6,497,536
- Allen Warren Jeffrey$2,507,651
- Justin Neal Bottsford-Miller$1,263,546
Others in their field
Top investigators on “Malignant Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Richard K. Wilson · Washington University$274,272,747
- Larry Arthur$223,443,122
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Research focus
Malignant NeoplasmsMedical SpecialtiesHealth Services AccessibilityInnovationCommunitiesMedically Underserved PopulationBaseEarly DiagnosisIdahoIndian ReservationCommunicationCancer HospitalDesignCancer SurvivorshipCancer TherapyCare DeliveryClinical TrialsCaringCancer CareGeographyClinical PracticeCancer CenterAreaMember
Grant awards (12)
Montana Cancer Consortium: An Inclusive and Collaborative Approach to Clinical Trial Accrual and Cancer Care Delivery Research across Montana, Idaho and Wyoming$755,012
UG1 · FY2025 · CA · contact PI
Montana Cancer Consortium: An Inclusive and Collaborative Approach to Clinical Trial Accrual and Cancer Care Delivery Research across Montana, Idaho and Wyoming$664,153
UG1 · FY2024 · CA · contact PI
Montana Cancer Consortium: An Inclusive and Collaborative Approach to Clinical Trial Accrual and Cancer Care Delivery Research across Montana, Idaho and Wyoming$1,069,045
UG1 · FY2023 · CA · contact PI
Montana Cancer Consortium: An Inclusive and Collaborative Approach to Clinical Trial Accrual and Cancer Care Delivery Research across Montana, Idaho and Wyoming$1,063,933
UG1 · FY2022 · CA · contact PI
Montana Cancer Consortium: An Inclusive and Collaborative Approach to Clinical Trial Accrual and Cancer Care Delivery Research across Montana, Idaho and Wyoming$972,381
UG1 · FY2021 · CA · contact PI
Montana Cancer Consortium: An Inclusive and Collaborative Approach to Clinical Trial Accrual and Cancer Care Delivery Research across Montana, Idaho and Wyoming$881,991
UG1 · FY2020 · CA · contact PI
Montana Cancer Consortium: An Inclusive and Collaborative Approach to Clinical Trial Accrual and Cancer Care Delivery Research across Montana, Idaho and Wyoming$872,332
UG1 · FY2019 · CA · contact PI
Montana Cancer Consortium NCORP$943,439
UG1 · FY2018 · CA
Montana Cancer Consortium NCORP$706,794
UG1 · FY2017 · CA
Montana Cancer Consortium NCORP$611,042
UG1 · FY2016 · CA
Montana Cancer Consortium NCORP$692,500
UG1 · FY2015 · CA
Montana Cancer Consortium NCORP$730,000
UG1 · FY2014 · CA